HUNgarian COronaVirus Disease-19 Epidemiological Research
Overview
Hungarian CoronaVirus disease-19 Epidemiological Research
Full Title of Study: “Hungarian CoronaVirus Disease-19 Epidemiological Research”
Study Type
- Study Type: Observational [Patient Registry]
- Study Design
- Time Perspective: Other
- Study Primary Completion Date: May 1, 2021
Detailed Description
The planned large-scale, cross-sectional, representative population screening can show the prevalence of COVID-19 and the degree of infection and trans-infection in Hungary after more than one month of strict restriction. In addition, it can have an impact on further actions, and we can track the impact of the decisions we make by repeating the screenings.
Clinical Trial Outcome Measures
Primary Measures
- COVID-19 rate
- Time Frame: 1 year
- The rate of the infected patients, asymptomatic carrier and healed patients
Participating in This Clinical Trial
Inclusion Criteria
- Hungarian male or female patients aged 14 and over who live in private households – Inactivated social security number does not infer the exclusion of the study Exclusion Criteria:
- Patients under the age of 14 – Patients living in institutional households
Gender Eligibility: All
Minimum Age: 14 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Semmelweis University Heart and Vascular Center
- Collaborator
- Semmelweis University
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Béla Merkely, PhD,DSc, Principal Investigator, Semmelweis University Heart and Vascular Center
- Overall Contact(s)
- Béla Merkely, PhD,DSc, +36 20 825 8000, rektor@semmelweis-univ.hu
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.